UNSPSC 51111641: Galocitabine

This classification denotes a pyrimidine antagonist with the molecular formula C19H22FN3O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X9788XI79O, chemically known as 5-deoxy-5-fluoro-n-(3,4,5-trimethoxybenzoyl)cytidine but generally known as galocitabine, which bears US NIH Compound Identifier 65950. European Medicines Agency schedules Galocitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07875MIG.

UNSPSC 51111641 Galocitabine, a Commodity code, covers pharmaceutical procurement by state and local health agencies, specifically the procurement of specialty and branded pharmaceutical products through direct-to-manufacturer or alternative distribution channel arrangements. State and local health and human services departments are the primary issuing bodies under this code, pursuing opportunities to establish direct relationships with pharmaceutical manufacturers or to restructure pharmacy benefit programs around negotiated net pricing and outcomes-based contracting models that bypass traditional pharmacy benefit managers and group purchasing organizations.

The Texas Health and Human Services Commission posted Request for Information No. HHS0017013 on April 3, 2026, to solicit vendor capabilities and market intelligence regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. The RFI seeks responses from vendors with experience in direct contracting for self-insured employers and health plans, flexibility to negotiate contracts based on negotiated net pricing models without rebates, and capability to implement value-based or outcomes-based agreements. As an exploratory procurement mechanism, the RFI is designed to inform the state's future procurement strategy and program design before issuing a formal RFP with established financial and temporal parameters. No award values, budget ranges, set-aside designations, or formal evaluation criteria are specified at this stage.